Skip to main content
Anteris Technologies Global Corp. logo

Anteris Technologies Global Corp. — Investor Relations & Filings

Ticker · AVR ISIN · US03675P1021 ASX Manufacturing
Open in API
Filings indexed 1,662 across all filing types
Latest filing 2026-02-24 Capital/Financing Update
Country US United States of America
Listing ASX AVR

About Anteris Technologies Global Corp.

https://anteristech.com/

Anteris Technologies is a structural heart company focused on the development and commercialization of medical devices for heart valve disease. Its lead product is the DurAVR® Transcatheter Heart Valve (THV), a biomimetic valve designed for patients with severe aortic stenosis. The DurAVR® THV is engineered to mimic the performance of a healthy human aortic valve, aiming to restore normal, laminar blood flow. Clinical studies have shown the device delivers a favorable hemodynamic profile, characterized by low pressure gradients and a significant reduction in prosthesis-patient mismatch (PPM), even in patients with challenging anatomies. The company is advancing its technology through pivotal clinical trials to establish a new standard in transcatheter aortic valve replacement (TAVR) and improve long-term patient outcomes.

Recent filings

Filing Released Lang Actions
Underwritten Offering - End of Stabilisation Period 2 pages 177.8KB
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the end of the stabilization period following an underwritten public offering by Anteris Technologies Global Corp. It details the exercise of underwriters' options and confirms that no market stabilization activities were undertaken. There are no financial statements, detailed financial data, or comprehensive report content. The document is short (4093 characters) and serves as a disclosure related to a financing event rather than a full financial report or earnings release. Therefore, it fits best under the category of Capital/Financing Update (CAP).
2026-02-24 English
4 - Anteris Technologies Global Corp. (0002011514) (Issuer)
Director's Dealing
2026-02-10 English
SCHEDULE 13G/A Filing
Major Shareholding Notification
2026-02-05 English
Statement of CDIs on issue - AVR 3 pages 12.9KB
Share Issue/Capital Change Classification · 95% confidence The document is titled 'Appendix 4A - Statement of CDIs on issue' and contains detailed information about the number and class of CHESS Depositary Interests (CDIs) and other securities on issue for the entity Anteris Technologies Global Corp. It includes monthly statements of securities issued, net differences from previous months, and reasons for changes such as transfers between CDIs and common stock on Nasdaq. The document is a regulatory announcement related to securities issued and changes in share capital structure, specifically a statement of securities on issue. It is not a full financial report, earnings release, or management discussion. The document length is 3189 characters, which is relatively short and focused on securities issued. This type of document corresponds to a Share Issue/Capital Change announcement, which covers new share issues, stock splits, or other capital changes. Therefore, the appropriate classification is SHA (Share Issue/Capital Change).
2026-02-04 English
Notification of cessation of securities - AVR 5 pages 17.2KB
Regulatory Filings Classification · 95% confidence The document is titled 'Appendix 3H - Notification of cessation of securities' and details the cessation (lapse) of certain securities such as restricted stock units and options for the entity Anteris Technologies Global Corp. It provides specific information about the securities that have ceased, reasons for cessation, and updated issued capital figures. This type of document is a regulatory announcement notifying the market and shareholders about changes in the status of securities, specifically cessation of securities. It is not a financial report, earnings release, or management discussion. It is a formal regulatory filing related to securities status changes. Therefore, the most appropriate classification is Regulatory Filings (RNS). The document length and content confirm it is not a brief announcement of a report (RPA) but a substantive regulatory notice.
2026-02-02 English
424B3
Regulatory Filings
2026-01-23 English

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.